Compare WVE & AVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | AVA |
|---|---|---|
| Founded | 2012 | 1889 |
| Country | Singapore | United States |
| Employees | N/A | 1929 |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 3.2B |
| IPO Year | 2015 | 1994 |
| Metric | WVE | AVA |
|---|---|---|
| Price | $13.35 | $39.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 3 |
| Target Price | $31.47 | ★ $38.67 |
| AVG Volume (30 Days) | ★ 2.2M | 636.6K |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | N/A | ★ 5.04% |
| EPS Growth | N/A | ★ 3.93 |
| EPS | N/A | ★ 2.38 |
| Revenue | $3,704,000.00 | ★ $1,964,000,000.00 |
| Revenue This Year | N/A | $0.20 |
| Revenue Next Year | $119.93 | $4.12 |
| P/E Ratio | ★ N/A | $16.36 |
| Revenue Growth | ★ 149.43 | 1.34 |
| 52 Week Low | $5.28 | $35.50 |
| 52 Week High | $21.73 | $43.50 |
| Indicator | WVE | AVA |
|---|---|---|
| Relative Strength Index (RSI) | 47.54 | 40.46 |
| Support Level | $12.53 | $36.51 |
| Resistance Level | $14.56 | $41.93 |
| Average True Range (ATR) | 0.79 | 0.82 |
| MACD | 0.01 | -0.27 |
| Stochastic Oscillator | 23.84 | 14.81 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P segment is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.